Comparison of tumor control outcomes and toxicity between LDR brachytherapy and high dose IMRT for clinically localized prostate cancer
To access this article, please choose from the options below
PII: S1538-4721(09)00012-9
doi:10.1016/j.brachy.2009.03.006
© 2009 Published by Elsevier Inc.
